GnRH in the Treatment of Hypogonadotropic Hypogonadism

Title:GnRH in the Treatment of Hypogonadotropic Hypogonadism

Volume: 27 Issue: 24

Author(s): Carlo Bettocchi*, Marco Rinaldi and Francesco Sebastiani

Affiliation:

• Department of Emergency and Organ Transplantation - Urology, Andrology, and Kidney Transplantation Unit - University of Bari,Italy

Keywords: GnRH, hypogonadotropic hypogonadism, hypogonadism treatment, fertility, idiopathic hypogonadotropic hypogonadism, Kallmann syndrome, combined pituitary hormone deficiency, cognition.

Abstract: Gonadotropin-releasing hormone (GnRH) is the focus of the scientific debate for the treatment of hypogonadotropic hypogonadism. Sexual maturation and reproductive function depend on the pulsatile secretion of GnRH that are mainly congenital and may or may not be associated with other genetic anomalies or syndromes. Clinical manifestations include a wide range of metabolic, endocrine, and psychologic dysfunctions. The following manuscript focuses on the effects of GnRH therapy on fertility and cognitive abilities, aiming to investigate the current level of evidence for this treatment regimen. Current literature has been reviewed with the aim of highlighting the key findings on these two aspects.

Cite this article as:

Bettocchi Carlo *, Rinaldi Marco and Sebastiani Francesco , GnRH in the Treatment of Hypogonadotropic Hypogonadism, Current Pharmaceutical Design 2021; 27 (24) . https://dx.doi.org/10.2174/1381612826666201125113319